Guido Baechler - 13 Feb 2026 Form 4 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Role
Chief Executive Officer, Director
Signature
/s/ Guido Baechler
Issuer symbol
MYNZ
Transactions as of
13 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 17:15:24 UTC
Previous filing
26 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BAECHLER GUIDO Chief Executive Officer, Director MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ /s/ Guido Baechler 19 Feb 2026 0001561662

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYNZ Ordinary Shares Award $0 +440,000 +267% $0.000000 605,058 13 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid.
F2 6,362 ordinary shares held, and 158,696 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026.